Search results
Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms
Investing.com· 1 day agoBiora Therapeutics (NASDAQ:BIOR) has announced significant advancements in its NaviCap and BioJet...
WHO clears Takeda's dengue vaccine
Reuters via AOL· 20 hours agoThe approval, called a prequalification, comes amidst a surge in mosquito-borne viral infections across Asia, Africa, and the Americas, including new...
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 hours agoBefore I turn the call over to Anthony for a review of our first quarter financials, I'd like to highlight that we've strengthened our balance sheet in recent weeks with a $1.2 million ...
BioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...
GuruFocus.com via Yahoo Finance· 19 hours agoExpected Operating Cash Burn: Approximately $20 million for Q2 2024, with a decrease anticipated in the second half of the year. Funding Operations: Current...and an 86% disease ...
New dengue vaccine approved by WHO as 6.7 million cases reported in Americas
Euronews via Yahoo News· 15 hours agoA new vaccine against dengue has been approved by the World Health Organization (WHO) as over 6 ...
Former Loretto Hospital executive accused of embezzling nearly $500,000
Chicago Sun-Times· 4 hours agoA former executive at Loretto Hospital has been charged with helping to embezzle nearly half a million dollars from the West Side facility during the COVID-19 pandemic. Heather ...
Working around your body clock could boost effectiveness of blood pressure drugs
The Telegraph via Yahoo News· 1 hour agoBlood pressure drugs are most effective earlier in the day if you are a morning person, and...
UN agency authorizes second vaccine against dengue amid outbreaks in the Americas
KAAL Austin· 19 hours agoIn a statement...pharmaceutical Takeda, recommending its use in children between six to 16 years old...
Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 21 hours agoThe company has initiated the Phase 2 proof of concept part of the 065-101 study, focusing on patients with specific chromosomal abnormalities, potentially addressing unmet medical needs. No ...
Ispire Technology Inc. Reports Fiscal Third Quarter 2024 Financial Results
FOX 4 Kansas City· 1 day agoTotal Revenue Increased 24% year-over-year to $30.0 Million Gross Profit Increased 35%...
